Page 168 - Abstract Book KONIKA 18
P. 168

Emergency & Pediatric Intensive Care

                                              P-EPIC-015
                     Two Cases of Multisystem Inflammation Syndrome in Children:
                               To Be or Not to Be Kawasaki Disease-Like

                         Ririe Fachrina Malisie, Hafaz Zakky Abdillah, Ayodhia Pitaloka Pasaribu
                   Child Health Department Medical Faculty Universitas Sumatera Utara, North Sumatera, Indonesia

                                               Abstract
            Background The multisystem inflammatory syndrome in children associated with Coronavirus Disease
            (COVID-19) named by CDC and WHO. Several studies have demonstrated the link between Kawasaki's
            disease and COVID-19 while some publications have not confirmed this relationship. It suggested that
            pathogenesis is related to host immune response and hyperinflammation. Objective To describe two cases in
            female toddler 4-years-old and 1.5-months-old infant diagnosed with MIS-C. Cases The first case presented
            high grade fever for several days before admission, non-purulent conjunctivitis, strawberry tongue and rash.
            There were increasing of C-reactive protein, procalcitonin, IL-6, ferritin, elevated of D-dimer, and antibody
            of SARS-CoV-2. Her initial echocardiogram described minimal pericardial effusion. She was treated with
            intravenous methylprednisolone, IVIG and aspirin. The fever diminished 48 hours after completion of
            IVIG. On the ambulatory department, her follow-up echocardiogram showed improvement in two weeks
            interval and no respiratory complications. The second case suffered fever and severe respiratory distress.
            The test of Ig G of SARS-CoV-2 was reactive but negative Polymerase Chain Reaction of SARS Co-V-
            2. Inflammation markers, cardiac enzymes and coagulation were increased significantly. The chest x-ray
            appeared bilateral infiltrates. She treated on mechanical ventilation and Vasoactive-Inotropic Score > 10.
            Electrocardiography showed Right Bundle Branch Block meanwhile echocardiography assessment described
            the dilatation of right atrial and myocarditis, before she have cardiac arrest and unsuccessful resuscitation.
            Conclusion The two cases of MIS-C have showed the differentiation of clinical symptoms, severity and
            laboratory presents between Kawasaki Disease-like or not.
                                 Keywords: MIS-C; COVID-19; Kawasaki disease-like

                                              P-EPIC-016
                     Patient Characteristic with High Flow Nasal Cannula Therapy
              in Pediatric Intensive Care Unit DR Mohammad Hoesin Hospital Palembang

                             Tessa Rulianty, Desti Handayani, Indra Saputra, Silvia Triratna
               Department of Child Health, Faculty of Medicine Universitas Sriwijaya, Mohammad Hoesin General Hospital,
                                      Palembang, South Sumatera, Indonesia

                                               Abstract
            Background High flow nasal cannula (HFNC) is increasingly utilized in paediatrics, delivering humidified air
            and oxygen for respiratory conditions causing hypoxia and distress. Few data exist regarding indications and
            characteristic patient that warrants HFNC in Pediatric Intensive Care Unit (PICU). Objective To identify the
            characteristic and outcome of patients with HFNC in PICU Mohammad Hoesin General Hospital Palembang.
            Methods The clinical data of patients admitted to PICU with HFNC from March until June 2021 were
            reviewed. All children, from 1 month to 18 years of age, with acute respiratory distress and HFNC therapy
            were eligible.  Results There were 34 subjects included in the study which represented 23,7% of total ICU
            admissions, 23/34 were male, median age was 36 (range 1-204) months. Majority of nutritional status was
            normal (13/34). HFNC therapy were used in pneumonia (18/34), neurologic diseases (5/34), post-extubation
            support (5/34), nephrology diseases (5/34), cardiac failure (1/34). Initial SpO2/FiO2 ratio <250 were found in
            33/34 subjects, except for one subject who had abnormal ventilation. HFNC was used successfully in 25/34
            patients with mean usage time 2.97 (SD 1) day. Conclusion HFNC was mostly indicated in pneumonia, and
            successfully used in more than half subjects.
                     Keywords: high-flow nasal cannula; child; respiratory distress, paediatric intensive care unit










            120                           KONIKA XVIII Abstract Book
   163   164   165   166   167   168   169   170   171   172   173